4D Molecular Therapeutics, Inc. · NASDAQ:FDMT
State Street Corp's stake in 4D Molecular Therapeutics, Inc. fell to 4.50% (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 10, 2026
State Street Corp's stake in 4D Molecular Therapeutics, Inc. fell to 4.50%, 2,469,425 shares, as a passive investor on Sep 30, 2026. Filed Nov 10, 2026 (Schedule 13G).
- Stake
- 4.50%
- Shares
- 2,469,425
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.50% | 2,469,425 |
Source
Download original · View original at SEC
Related
- 4D Molecular Therapeutics, Inc.
- State Street Corp
- 4D Molecular Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · May 12, 2026
- Schedule 13G/A · Bvf Partners L P · Nov 16, 2026
- Schedule 13G/A · Novo Holdings A/S · Nov 16, 2026
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026